WHO ICTRP trial
Use of the PKD1 Sequencing Assay in Vertex's Phase 2a Study of VX-407 for…
NL-OMON58178 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON58178 |
|---|---|
| Public title | Use of the PKD1 Sequencing Assay in Vertex's Phase 2a Study of VX-407 for Subjects with ADPKD Who Have a Subset of PKD1 Gene Variants |
| Scientific title | Utilization of the Labcorp PKD1 Sequencing Assay in Support of Vertex’s Phase 2a Clinical Evaluation of VX-407 in Subjects with Autosomal Dominant Polycystic Kidney Disease Who Have a Subset of PKD1 Gene Variants - Labcorp PKD1 Sequencing Assay Performance Evaluation Study |
| Primary sponsor | Labcorp Holdings, Inc |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Belgium;United States;Spain;Canada;Germany;France;United Kingdom;Italy;Netherlands |
| Conditions | Autosomal Dominant Polycystic Kidney Disease (ADPKD) kidney disease;10038360 |
| Interventions | Labcorp PKD1 Sequencing AssayThe Labcorp PKD1 Sequencing Assay is a qualitative next generation sequencing-based in vitro diagnostic device that uses gene-specific long-range PCR (LR-PCR) for target enrichment. The assay is intended to… |
| Registration date | Jul 23, 2025 |
| Target size | 2 |
| Secondary IDs | NL-010491 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: